21 yritystä salkkuni 24 yrityksestä on julkaissut osavuosikatsauksensa ja Fortumilta, Booking Holdingilta ja Medtronicilta raportti on vielä matkalla.
Fastenal (Q1, 14.4.)
- Net sales increased $57.7, or 4.4%, in the first quarter of 2020 when compared to the first quarter of 2019.
- Our net earnings during the first quarter of 2020 were $202.6, an increase of 4.4% when compared to the first quarter of 2019.
- Our diluted net earnings per share were $0.35 during the first quarter of 2020 compared to $0.34 during the first quarter of 2019, an increase of 4.0%.
- We signed 4,798 industrial vending devices during the first quarter of 2020. Our installed device count on March 31, 2020 was 92,124, an increase of 10.4% over March 31, 2019.
Texas Instruments (Q1, 21.4.)
- Revenue decreased 7% from the same quarter a year ago.
- Our cash flow from operations of $6.4 billion for the trailing 12 months again underscored the strength of our business model.
- Free cash flow for the same period was $5.6 billion and 40% of revenue.
- We have returned $6.6 billion to owners in the past 12 months through stock repurchases and dividends. Over the same period, our dividends represented 55% of free cash flow, underscoring their sustainability. Together, our stock repurchases and dividends reflect our continued commitment to return all free cash flow to our owners.
- With a COVID-19 recession likely upon us, and with reduced visibility of customer demand, we are using the 2008 financial crisis to model our second quarter outlook. To reflect the increased uncertainty, we have expanded the range of our guidance. Therefore, TI's second quarter outlook is for revenue in the range of $2.61 billion to $3.19 billion, and earnings per share between $0.64 and $1.04.
Kone (Q1, 22.4.)
- Orders received grew by 0.7% to EUR 2,109.3 (1–3/2019: 2,094.1) million. At comparable exchange rates, orders grew by 0.3%.
- Sales were stable at EUR 2,198.3 (2,198.8) million. At comparable exchange rates, sales declined by 0.5%.
- Operating income (EBIT) was EUR 197.2 (215.4) million or 9.0% (9.8%) of sales. The adjusted EBIT was EUR 205.6 (228.4) million or 9.4% (10.4%) of sales.*
- Cash flow from operations (before financing items and taxes) was EUR 346.9 (377.6) million
Svenska Handelsbanken (Q1, 22.4.)
- Strong capital situation and liquidity. The common equity tier 1 ratio increased to 17.6% (16.4).
- Stable credit quality. The credit loss ratio was 0.08% (0.05). 0.07% of this amount was attributable to additional provision requirements for expected credit losses.
- Return on equity went down to 10.3% (13.4).
Tractor Supply (Q1, 23.4.)
- Net Sales Increased 7.5%; Comparable Store Sales Increased 4.3%
- Diluted Earnings Per Share Increased 12.7% to $0.71
- Actions Taken to Prioritize Investments in Safety and Convenience and Improve Liquidity
3M (Q1, 28.4.)
- Sales of $8.1 billion, up 2.7 percent year-on-year
- Organic local-currency sales grew 0.3 percent year-on-year
- GAAP EPS of $2.22; adjusted EPS of $2.16
- Operating cash flow of $1.2 billion, up 16 percent year-on-year; adjusted free cash flow of $0.9 billion, up 40 percent year-on-year
- Withdraws full-year 2020 guidance due to COVID-19 impact and end-market uncertainty
Starbucks (Q2, 28.4.)
- Global comparable store sales declined 10%, driven by a 13% decrease in comparable transactions, partially offset by a 4% increase in average ticket.
- The company opened 255 net new stores in Q2, yielding 6% year-over-year unit growth, ending the period with 32,050 stores globally, of which 51% and 49% were company-operated and licensed, respectively.
- Consolidated net revenues of $6.0 billion declined 5% from the prior year due to lost sales related to the COVID-19 outbreak.
- GAAP Earnings Per Share of $0.28, down 47% from the prior year primarily due to unfavorable impacts related to the COVID-19 outbreak
Automatic Data Processing (Q3, 29.4.)
- Revenues increased 6% to $4.0 billion; 6% organic constant currency
- Employer Services New Business Bookings decreased 9%
- Net earnings increased 9% to $821 million, and adjusted net earnings increased 8% to $829 million
- Adjusted EBIT increased 8% to $1,097 million, and adjusted EBIT margin expanded 60 basis points to 27.1%
- Diluted earnings per share ("EPS") increased 10% to $1.90 for the quarter, and adjusted diluted EPS increased 8% to $1.92
- Revising fiscal 2020 outlook in light of the expected impact from COVID-19
Strategic Education (Q1, 29.4.)
- Revenue increased 7.6% to $265.3 million compared to $246.5 million for the same period in 2019.
- Diluted earnings per share was $1.60 compared to $0.52 for the same period in 2019. Adjusted diluted earnings per share increased to $2.11 from $1.66 for the same period in 2019. Diluted weighted average shares outstanding increased to 22,071,000 from 22,050,000 for the same period in 2019.
- For the first quarter, student enrollment at Strayer University increased 11% to 55,337 compared to 49,886 for the same period in 2019. New student enrollment for the period increased 7% and continuing student enrollment for the period increased 12%.
- For the first quarter, student enrollment at Capella University increased 4% to 41,200 compared to 39,700 for the same period in 2019. New student enrollment for the period increased 17% and continuing student enrollment for the period increased 1%.
Intercontinental Exchange (Q1, 30.4.)
- Record first quarter revenues of $1.6 billion, +23% y/y
- GAAP diluted EPS of $1.17, +38% y/y; Adj. diluted EPS of $1.28, +39% y/y
- Operating margin of 57%; Adj. operating margin of 62%
- Operating income +32% y/y; Adj. operating income +30% y/y
Aflac (Q1, 30.4.)
- Total revenues were $5.2 billion during the first quarter of 2020, compared with $5.7 billion in the first quarter of 2019.
- Net earnings were $566 million, or $0.78 per diluted share, compared with $928 million, or $1.23 per diluted share a year ago.
- Net earnings in the first quarter of 2020 included pretax net investment losses of $448 million, or $0.62 per diluted share, compared with pretax net investment gains of $103 million, or $0.14 per diluted share a year ago.
- Total investments and cash at the end of March 2020 were $137.0 billion, compared with $131.4 billion at March 31, 2019.
- The annualized adjusted return on equity excluding foreign currency impact* in the
first quarter was 15.7%.
- Combined ratio 80.7%.
Altria (Q1, 30.4.)
- Net revenues increased 13.0% to $6.4 billion, primarily due to higher net revenues in the smokeable and oral tobacco products segments. Revenues net of excise taxes increased 15.0% to $5.0 billion.
- Reported diluted EPS increased 38.3% to $0.83, primarily driven by higher reported operating companies income (OCI) in the smokeable and oral tobacco products segments, lower charges for Cronos-related special items, 2019 acquisition-related costs associated with the JUUL and Cronos transactions, higher reported earnings from Altria’s equity investment in ABI and fewer shares outstanding, partially offset by higher asset, exit, implementation and acquisition-related costs.
- Adjusted diluted EPS increased 18.5% to $1.09, primarily driven by higher adjusted OCI in the smokeable and oral tobacco products segments and fewer shares outstanding, partially offset by lower adjusted earnings from Altria’s equity investment in ABI.
Moodys (Q1, 30.4.)
- Moody's Corporation 1Q20 revenue of $1.3 billion, up 13% from 1Q19
- Moody's Investors Service revenue of $794 million, up 19%; Moody's Analytics revenue of $496 million up 5%, excluding acquisitions and divestitures up 9%
- 1Q20 diluted EPS of $2.57 up 33% from 1Q19; adjusted diluted EPS of $2.73 up 32% 1
- FY 2020 diluted EPS and adjusted diluted EPS guidance ranges reduced to $7.25 to $7.85 and $7.80 to $8.40, respectively due to anticipated COVID-19 impacts
Visa (Q2, 30.4.)
- GAAP net income of $3.08B or $1.38 per share and non-GAAP net income of $3.10B or $1.39 per share
- Net revenues of $5.9B, an increase of 7%
- As a result of the COVID-19 outbreak, growth in the underlying business drivers slowed during the
quarter, with significant declines in the month of March
Stryker (Q1, 30.4.)
- Reported net sales increased 2.0% to $3.6 billion
- Organic net sales increased 2.4%
- Reported operating income margin of 17.7%
- Adjusted operating income margin(1) contracted 110 bps to 24.0%
- Reported EPS increased 19.3% to $1.30
- Adjusted EPS(1) decreased 2.1% to $1.84
Gilead Science (Q1, 30.4.)
- Total revenues for the first quarter 2020 were $5.5 billion, an increase of 5% compared to the same period in 2019.
- Net income for the first quarter 2020 was $1.6 billion or $1.22 per diluted share, a decrease of 21% compared to the same period in 2019.
- Total product sales for the first quarter 2020 were $5.5 billion compared to $5.2 billion for the same period in 2019.
- HIV product sales were $4.1 billion for the first quarter 2020 compared to $3.6 billion for the same period in 2019.
- As of March 31, 2020, Gilead had $24.3 billion of cash, cash equivalents and marketable debt securities, compared to $25.8 billion as of December 31, 2019.
Skyworks Solutions (Q2, 4.5.)
- Delivers Revenue of $766.1 Million
- Posts GAAP Diluted EPS of $1.06; Non-GAAP Diluted EPS of $1.34
- Generates $280.4 Million in Cash Flow from Operations
- Ended Quarter with $1.1 Billion in Cash and Investments and No Debt
Illinois Tool Works (Q1, 5.5.)
- First quarter revenue of $3.2 billion declined 9.1 percent with organic revenue down 6.6 percent.
- GAAP EPS of $1.77, a decrease of 2%
- Operating margin of 23.6%
- Free cash flow was 98% of net income
- Strong financial position and balance sheet with $1.4 billion of cash on hand, essentially no short-term debt, and a revolving credit facility in place that could provide additional liquidity of $2.5 billion
Nokian Renkaat (Q1, 5.5.)
- Net sales were EUR 279.8 million (340.3 in January−March 2019). With comparable currencies,
net sales decreased by 16.5% especially due to measures taken to reduce high carry-over stocks
in the Russian distribution channel, slowing economic activity caused by COVID-19, and mild
winter in all main markets.
- Segments operating profit was EUR 16.3 million (56.7), with no significant currency impact. The
decline was due to lower volumes and underabsorption of factory costs. Operating profit was
EUR 9.0 million (53.9).
- Segments earnings per share were EUR 0.09 (1.44, positively impacted by EUR 1.08 related to
the rulings on the tax disputes). Earnings per share were EUR 0.02 (1.41, positively impacted by
EUR 1.08 related to the rulings on the tax disputes).
- Cash flow from operating activities was EUR -38.9 million (-68.9).
Disney (Q2, 6.5.)
- Diluted earnings per share (EPS) from continuing operations for the quarter decreased 93% to $0.26 from $3.53 in the prior-year quarter.
- Media Networks revenues for the quarter increased 28% to $7.3 billion, and segment operating income increased 7% to $2.4 billion.
- Cable Networks revenues for the quarter increased 17% to $4.4 billion and operating income increased 1% to $1.8 billion.
- Broadcasting revenues for the quarter increased 49% to $2.8 billion and operating income increased 53% to $397 million.
- Parks, Experiences and Products revenues for the quarter decreased 10% to $5.5 billion, and segment operating income decreased 58% to $639 million.
- Studio Entertainment revenues for the quarter increased 18% to $2.5 billion and segment operating income decreased 8% to $466 million.
- Direct-to-Consumer & International revenues for the quarter increased from $1.1 billion to $4.1 billion and segment operating loss increased from $385 million to $812 million.
- Disney+ had 33.5 million paid subscribers with average monthly revenue of $5.63.
Novo Nordisk (Q1, 6.5.)
- Sales in International Operations increased by 19% in Danish kroner (19% at CER), driven by growth in all areas. Sales in North America Operations increased by 12% in Danish kroner (9% at CER). In both operating units, sales were impacted by COVID-19-related stocking.
- Sales within Diabetes and Obesity care increased by 15% to DKK 28.6 billion (14% at CER), driven by Diabetes care growing by 13% at CER and Obesity care growing by 30% at CER. Sales within Biopharm increased by 18% to DKK 5.3 billion (16% at CER).
- Sales of GLP-1 increased by 40% in Danish kroner (37% at CER) reflecting the solid uptake of Ozempic®. In the US, Rybelsus® market access is progressing and the weekly new-to-brand market share has reached 8.8%.
- The pipeline progressed with approval of Rybelsus® in the EU and successful completion of the phase 2 trial with semaglutide in NASH, both in April.
Yhteenvetona alla vielä taulukko, jossa kaikkien yritysten liikevaihdon muutokset raportoidun kvartaalin aikana vuoden takaiseen verrattuna.
|Texas Instruments||-7,0 %|
|Svenska Handelsbanken||4,0 %|
|Tractor Supply||7,5 %|
|Automatic Data Processing||6,0 %|
|Strategic Education||7,6 %|
|Intercontinental Exchange||23,0 %|
|Skyworks Solutions||-5,5 %|
|Illinois Tool Works||-9,1 %|
|Nokian Renkaat||-16,5 %|
|Novo Nordisk||19 %|